Beaumont Asset Management, L.L.C. Amgen Inc Transaction History

Beaumont Asset Management, L.L.C.

$169 Million
Q3 2024

A detailed history of Beaumont Asset Management, L.L.C. transactions in Amgen Inc stock. As of the latest transaction made, Beaumont Asset Management, L.L.C. holds 1,687 shares of AMGN stock, worth $446,194. This represents 0.32% of its overall portfolio holdings.

Number of Shares

1,687

Previous 1,687 -0.0%

Holding current value

$446,194

Previous $527,000 3.04%

% of portfolio

0.32%

Previous 0.34%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 01, 2024	BUY	$255.7 - $288.46 $15,853 - $17,884	62 Added 3.82%	1,687 $485,000
Q3 2023 Oct 30, 2023	SELL	$218.65 - $271.46 $14,430 - $17,916	-66 Reduced 3.9%	1,625 $436,000
Q4 2022 Jan 18, 2023	BUY	$229.03 - $291.01 $229 - $291	1 Added 0.06%	1,691 $0
Q3 2022 Nov 01, 2022	SELL	$224.46 - $253.15 $63,971 - $72,147	-285 Reduced 14.43%	1,690 $381,000
Q2 2022 Jul 19, 2022	SELL	$230.71 - $256.74 $17,995 - $20,025	-78 Reduced 3.8%	1,975 $480,000
Q1 2022 May 02, 2022	SELL	$219.27 - $242.57 $2,192 - $2,425	-10 Reduced 0.48%	2,053 $496,000
Q2 2021 Aug 12, 2021	SELL	$233.58 - $259.14 $1.88 Million - $2.08 Million	-8,028 Reduced 79.56%	2,063 $502,000
Q1 2021 Apr 29, 2021	BUY	$221.91 - $258.6 $69,457 - $80,941	313 Added 3.2%	10,091 $2.51 Million
Q4 2020 Feb 04, 2021	BUY	$216.38 - $257.67 $21,205 - $25,251	98 Added 1.01%	9,778 $2.25 Million
Q3 2020 Oct 14, 2020	SELL	$234.65 - $260.95 $69,691 - $77,502	-297 Reduced 2.98%	9,680 $2.46 Million
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $28,880 - $35,440	146 Added 1.49%	9,977 $2.35 Million
Q1 2020 Apr 21, 2020	SELL	$182.24 - $241.7 $86,746 - $115,049	-476 Reduced 4.62%	9,831 $1.99 Million
Q4 2019 Jan 29, 2020	BUY	$189.21 - $243.2 $1.95 Million - $2.51 Million	10,307 New	10,307 $2.48 Million

Others Institutions Holding AMGN

# of Institutions

3,125

Shares Held

409M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $141B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beaumont Asset Management, L.L.C., based on Form 13F filings with the SEC.

News

Stay updated on Beaumont Asset Management, L.L.C. with notifications on news.

Account

Beaumont Asset Management, L.L.C. Amgen Inc Transaction History